Tovorafenib

Treatment for: Low-Grade Glioma Day One Announces New FIREFLY-1 Data for Tovorafenib (DAY101) and Initiation of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma BRISBANE, Calif., […]

» Read more
1 2 3 4 1,711